Form 4: HealthEquity Director Sells 5,000 Shares

Debra Charlotte McCowan, a director at HealthEquity, Inc., sold 5,000 shares of common stock on December 12, 2024.

Summary

• Debra Charlotte McCowan, a director of HealthEquity, Inc., sold 5,000 shares of the company's common stock on December 12, 2024.
• The sale was executed at a weighted average price of $95.56 per share.
• The shares were sold in multiple transactions with prices ranging from $95.55 to $95.63.
• Following the transaction, Ms. McCowan beneficially owns 7,779 shares of HealthEquity common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale by a company director. It does not convey any specific positive or negative sentiment.

Industry Context

This is a routine filing related to insider trading activity and is common for publicly traded companies. It does not indicate any specific trend in the health technology sector.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders.
• The sale of 5,000 shares by a director is not unusual and does not indicate any specific trend compared to other companies in the sector.
• Similar filings are made by directors and officers of companies like Teladoc Health and Livongo Health when they trade their company's stock.

Stakeholder Impact

• The sale of shares by a director may have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's stock price.

Key Dates

Keywords

HealthEquity, HQY, stock sale, insider trading, director, Debra Charlotte McCowan